Article
Epidermal growth factor increases coactivation of the androgen receptor in recurrent prostate cancer.
The Journal of biological chemistry - 20 Feb 2004
Gregory Christopher W, Fei Xiaoyin, Ponguta Liliana A, He Bin, Bill Heather M, French Frank S, Wilson Elizabeth M
Abstract excerpt
Growth of normal and neoplastic prostate is mediated by the androgen receptor (AR), a ligand-dependent transcription factor activated by high affinity androgen binding. The AR is highly expressed in recurrent prostate cancer cells that proliferate despite reduced circulating androgen. In this report, we show that epidermal growth factor (EGF) increases androgen-dependent AR transactivation in the recurrent...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
